title: Infliximab for the treatment of granulomatous peritonitis.
authors.affiliation: Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Lucile Packard Children's Hospital, Stanford University Medical Center, Palo Alto, CA, USA, annming@stanford.edu.
authors.forename: Ann Ming
authors.initials: AM
authors.lastname: Yeh
authors.forename: John
authors.initials: J
authors.lastname: Kerner
authors.forename: Paula
authors.initials: P
authors.lastname: Hillard
authors.forename: Dorsey
authors.initials: D
authors.lastname: Bass
mesh_terms: D000008:Abdominal Neoplasms / Q000150:complications*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D002648:Child; D003884:Dermoid Cyst / Q000150:complications*; D006099:Granuloma / Q000209:etiology*; D006801:Humans; D000069285:Infliximab; D010538:Peritonitis / Q000188:drug therapy / Q000209:etiology*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D000069285:Infliximab